Health
New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation – News-Medical.Net
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million…
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
The grant will aid the effort to bring further preclinical validation to the AAV vaccine platform. An AAVCOVID vaccine candidate is set to enter clinical trials in 2021.
The AAVCOVID vaccine program was founded at Mass General Brigham at the outset of the pandemic.
Preliminary tests of the vaccines’…
-
Noosa News21 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General19 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
General14 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General7 hours agoThe one tweak that could grow your super by $200,000